Mohalao, Rasida A.
HRN: 23-30-08 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/10/2023
CEFUROXIME 500MG (TAB)
07/10/2023
07/16/2023
PO
1 Tab
BID
S/p RMLE
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes